Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
Move Over Ozempic, Here Comes Petrelintide
Roche has signed a multi-billion dollar deal with Zealand Pharma to develop the weight loss drug petrelintide.
The Role of the Gut Microbiome in Addiction
Researchers at the University of Wisconsin explore the relationship between the gut microbiome and addiction.
Understanding GLP-1 Discontinuation Rates
Half of the people who take GLP-1 drugs such as Ozempic quit within the first year. Why?
Akrasia, Biased Choice, and the Unified Theory of Addiction
In concluding his book, A New Approach to Addiction and Choice, Dr. Reinout W. Wiers stumbles upon the Unified Theory of Addiction.
The Anticipation Wrinkle, The Expectation Wrinkle, and the Neurocircuitry of Addiction
Addicts get hooked on thinking about indulging to a degree that consuming is a letdown.